BR0314592A - Processo para preparação de intermediários - Google Patents

Processo para preparação de intermediários

Info

Publication number
BR0314592A
BR0314592A BR0314592-1A BR0314592A BR0314592A BR 0314592 A BR0314592 A BR 0314592A BR 0314592 A BR0314592 A BR 0314592A BR 0314592 A BR0314592 A BR 0314592A
Authority
BR
Brazil
Prior art keywords
preparing intermediates
intermediates
preparing
lactarn
directed
Prior art date
Application number
BR0314592-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Prasad Koteswara Kapa
Xinglong Jiang
Eric M Loeser
Joel Slade
Mahavir Prashad
George Tien-San Lee
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0314592A publication Critical patent/BR0314592A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Press Drives And Press Lines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BR0314592-1A 2002-09-19 2003-09-18 Processo para preparação de intermediários BR0314592A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41192002P 2002-09-19 2002-09-19
US48024203P 2003-06-20 2003-06-20
PCT/EP2003/010416 WO2004026824A1 (en) 2002-09-19 2003-09-18 Process for preparing intermediates

Publications (1)

Publication Number Publication Date
BR0314592A true BR0314592A (pt) 2005-08-09

Family

ID=32033579

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314592-1A BR0314592A (pt) 2002-09-19 2003-09-18 Processo para preparação de intermediários

Country Status (20)

Country Link
US (1) US7589216B2 (enExample)
EP (1) EP1542968B1 (enExample)
JP (1) JP2006503053A (enExample)
KR (1) KR20050057429A (enExample)
CN (1) CN100439334C (enExample)
AT (1) ATE417826T1 (enExample)
AU (1) AU2003273404B2 (enExample)
BR (1) BR0314592A (enExample)
CA (1) CA2499426A1 (enExample)
DE (1) DE60325390D1 (enExample)
DK (1) DK1542968T3 (enExample)
EC (1) ECSP055692A (enExample)
ES (1) ES2321504T3 (enExample)
MX (1) MXPA05003089A (enExample)
NO (1) NO20051867L (enExample)
NZ (1) NZ538833A (enExample)
PL (1) PL374961A1 (enExample)
PT (1) PT1542968E (enExample)
RU (1) RU2374227C2 (enExample)
WO (1) WO2004026824A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1512991A (zh) 2001-06-15 2004-07-14 ά����ҩ�﹫˾ 吡咯烷双环化合物
EP1542968B1 (en) 2002-09-19 2008-12-17 Novartis AG Process for preparing intermediates
JP2006519786A (ja) 2003-02-21 2006-08-31 ノバルティス アクチエンゲゼルシャフト N−ホルミルヒドロキシルアミン化合物を得るための中間体作成に関する化学的方法
GT200600196A (es) * 2005-05-23 2007-01-15 Compuestos n-formil de hidroxilamina
CN101434570B (zh) * 2007-11-16 2011-02-02 上海医药工业研究院 吡咯烷衍生物及其制备方法和应用
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU384814A1 (ru) * 1970-12-25 1973-05-29 Всесоюзный научно исследовательский институт тетических , натуральных душистых веществ СПОСОБ ПОЛУЧЕНИЯ р-МЕТИЛЗАМЕЩЕННЫХ со-ОКСИКАРБОНОВЫХ КИСЛОТ
US4115417A (en) 1975-10-16 1978-09-19 Hoffmann-La Roche Inc. Asymmetric hydrogenation catalyzed by rhodium complexes of chiral tertiary phosphines
JPS5377010A (en) * 1976-12-16 1978-07-08 Mitsui Toatsu Chem Inc Preparation of hydroxypivalic acid
JPS6030666B2 (ja) 1980-08-20 1985-07-17 鐘淵化学工業株式会社 光学活性メルカプトカルボン酸の製造法
JPS5953839B2 (ja) * 1980-10-06 1984-12-27 鐘淵化学工業株式会社 (−)−α−ヒドロキシメチル酪酸の製造方法
JPH01149751A (ja) * 1987-12-08 1989-06-12 Agency Of Ind Science & Technol 2−n−ヘキシル−3−ヒドロキシ−n−デカン酸及びそのエステル
AU633260B2 (en) 1988-08-09 1993-01-28 Genencor International, Inc. Chiral hydroxycarboxylic acids from prochiral diols
JPH0592948A (ja) * 1991-02-06 1993-04-16 Yoshitomi Pharmaceut Ind Ltd プロピオン酸アミド誘導体およびその医薬用途
NZ505675A (en) 1998-02-07 2002-11-26 British Biotech Pharm N-alkylamide substituted hydroxamic acid derivatives are used as antibacterial agents
US6977141B2 (en) 1998-02-10 2005-12-20 Vicuron Pharmaceuticals Inc. Direct adsorption scintillation assay for measuring enzyme activity and assaying biochemical processes
AR032920A1 (es) * 2001-03-01 2003-12-03 Smithkline Beecham Corp Compuestos inhibidores de las peptido-deformilasas y medios para tratar infecciones bacterianas utilizando dichos inhibidores
CN1512991A (zh) 2001-06-15 2004-07-14 ά����ҩ�﹫˾ 吡咯烷双环化合物
AR036053A1 (es) 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
JP2006052138A (ja) * 2002-08-23 2006-02-23 Dainippon Sumitomo Pharma Co Ltd プロリン誘導体
EP1542968B1 (en) 2002-09-19 2008-12-17 Novartis AG Process for preparing intermediates
JP2006519786A (ja) 2003-02-21 2006-08-31 ノバルティス アクチエンゲゼルシャフト N−ホルミルヒドロキシルアミン化合物を得るための中間体作成に関する化学的方法
TW200427458A (en) 2003-04-02 2004-12-16 Novartis Ag Crystalline N-formyl hydroxylamine compounds
AU2004251876A1 (en) 2003-06-26 2005-01-06 Novartis Ag Process for preparing intermediates useful to prepare certain antibacterial N-formyl hydroxylamines

Also Published As

Publication number Publication date
HK1079513A1 (en) 2006-04-07
NZ538833A (en) 2008-05-30
PL374961A1 (en) 2005-11-14
EP1542968B1 (en) 2008-12-17
AU2003273404B2 (en) 2008-05-22
ATE417826T1 (de) 2009-01-15
ES2321504T3 (es) 2009-06-08
CN1684945A (zh) 2005-10-19
US7589216B2 (en) 2009-09-15
NO20051867D0 (no) 2005-04-18
ECSP055692A (es) 2005-07-06
MXPA05003089A (es) 2005-05-27
RU2005111600A (ru) 2006-10-27
DE60325390D1 (de) 2009-01-29
DK1542968T3 (da) 2009-04-20
JP2006503053A (ja) 2006-01-26
NO20051867L (no) 2005-04-18
US20050261504A1 (en) 2005-11-24
WO2004026824A1 (en) 2004-04-01
EP1542968A1 (en) 2005-06-22
AU2003273404A1 (en) 2004-04-08
CA2499426A1 (en) 2004-04-01
KR20050057429A (ko) 2005-06-16
PT1542968E (pt) 2009-03-25
RU2374227C2 (ru) 2009-11-27
CN100439334C (zh) 2008-12-03

Similar Documents

Publication Publication Date Title
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
EA200702346A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
BR0308158B1 (pt) processo para o melhoramento de correntes brutas de hidrocarbonetos.
DK1651621T3 (da) 2-(Quinoxalin-5-ylsulfonylamino)benzamidforbindelser som CCK2-modulatorer
BRPI0518459A2 (pt) composto ou um sal farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, uso de um composto, e, processo para preparar o composto ou um sal farmaceuticamente aceitÁvel do mesmo
BRPI0710199A2 (pt) Processo para preparação de inibidores de hiv protease
EA201101015A1 (ru) Способ получения бивалирудина
EA200601029A1 (ru) Способ очистки фсг
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
BRPI0715051A2 (pt) Processo e intermediários para a síntese de derivados de 2-(quinolin-5il)-4,5 dissubstituído-azol
BR0314592A (pt) Processo para preparação de intermediários
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
BRPI0508430A (pt) processo para a preparação de inibidores da triptase
BRPI0411921A (pt) processo para preparar intermediários úteis para preparar determinadas hidroxilaminas de n-formila antibacterianas
MXPA05012004A (es) Nuevos bioisosteros de actinonina.
CO6390054A2 (es) Formas cristalinas de un compuesto 3-carboxipropil-aminotetralina
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
ATE411310T1 (de) Reinigungsverfahren von moxonidine
BR0315508A (pt) Processo para preparação de compostos de pirazol
ITMI20020934A0 (it) Processo per la sintesi di benazepril cloridrato
ATE440848T1 (de) Synthese von proteaseinhibitorvorstufen
BR0315348A (pt) Processo para a preparação de um composto, e composto

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. C07D 207/16, 205/08, C07C 271/16, 59/01, 309/65; A61P 31/00

Ipc: C07D 207/16 (2011.01), C07D 205/08 (2011.01), C07C

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2143 DE 31/01/2012.